Cleared Traditional

Optional Screen Display for HeartSee Cardiac P.E.T. Processing Software - HeartSee version 3 (K202679) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
209d
Days
Class 2
Risk

K202679 is an FDA 510(k) clearance for the Optional Screen Display for HeartSee Cardiac P.E.T. Processing Software - Hea.... Classified as System, Tomography, Computed, Emission (product code KPS), Class II - Special Controls.

Submitted by Mcgovern Medical School (Houston, US). The FDA issued a Cleared decision on April 12, 2021 after a review of 209 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1200 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Mcgovern Medical School devices

Submission Details

510(k) Number K202679 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2020
Decision Date April 12, 2021
Days to Decision 209 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 107d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPS System, Tomography, Computed, Emission
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPS System, Tomography, Computed, Emission

All 177
Devices cleared under the same product code (KPS) and FDA review panel - the closest regulatory comparables to K202679.
Symbia VA10A Family
K210557 · Siemens Medical Solutions USA, Inc. · May 2021
HYPER AiR
K210001 · Shanghai United Imaging Healthcare Co., Ltd. · Apr 2021
Cartesion Prime (PCD-1000A/3) V10.8
K203314 · Canon Medical Systems Corporation · Apr 2021
HYPER Focus
K210418 · Shanghai United Imaging Healthcare Co., Ltd. · Apr 2021
StarGuide
K210173 · Ge Healthcare · Mar 2021
BBX-PET Scanner
K210450 · Prescient Imaging, LLC · Mar 2021